Skip to main content
. Author manuscript; available in PMC: 2010 Feb 18.
Published in final edited form as: Cancer Lett. 2008 Nov 5;274(2):313–318. doi: 10.1016/j.canlet.2008.09.033

Fig. 2.

Fig. 2

Bevacizumab has no effect on tumor cells in vitro. Tumor cells from the FaDu and FaDu/siE cell lines were plated with and without normal dermal fibroblasts were treated with 0, 25, 50 and 75 ng/mL of bevacizumab. After 72 hours, cells were trypsinized and counted. Bevacizumab had no effect on cell growth, regardless of EMMPRIN expression (P ≥ 0.086).